Specifications
| SKU | ISG017083 |
| Shop by Concerns | Chronic Gouty Arthritis |
| Gender | Neutral |
| Shop By Goals | Pain relief |
| Imported Or Local | Special Import |
| Ingredient | Colchicine |
| UPC | 240573538760 |
| Product Form | Tablets |
| Specialty | Anti-Inflammatory |
| Sub Categories | Gout Medicines |
| Warning | Use under medical supervision |
About the product›
Product Description:
Colchicina/Acarpia 1 mg is an oral medication manufactured by Acarpia Farmaceutici in Greece, designed specifically for the effective treatment of acute gout attacks and the prevention of future episodes in patients with chronic gouty arthritis. Each tablet contains 1 mg of colchicine, a potent anti-inflammatory agent that alleviates pain and inflammation associated with gout flare-ups.
Indications:
This medication is indicated for the treatment of acute gout crises and for preventing new crises in individuals suffering from chronic gouty arthritis.
Dosage and Administration:
The recommended dosage for acute gout attacks is 1 mg (one tablet) at the first sign of an attack. If pain persists, a second dose of 1 mg may be administered one to two hours later, with a maximum limit of 2 mg within a 24-hour period.
Clinical Benefits:
Colchicina/Acarpia effectively reduces the pain and inflammation associated with acute gout attacks, providing relief to patients and supporting joint health.
Active Ingredients:
Each tablet contains 1 mg of colchicine as the active ingredient.
Warnings and Contraindications:
Use of this medication should be under medical supervision due to the narrow therapeutic margin of colchicine. It is contraindicated in patients with known allergies to colchicine and in those with severe gastrointestinal, hepatic, renal, or cardiac diseases.
Side Effects:
Possible side effects may include diarrhea, nausea, vomiting, abdominal cramps, and pain. It is essential to adhere to medical guidance regarding dosage and treatment duration to avoid health risks associated with self-medication.
Colchicina/Acarpia 1 mg is an oral medication manufactured by Acarpia Farmaceutici in Greece, designed specifically for the effective treatment of acute gout attacks and the prevention of future episodes in patients with chronic gouty arthritis. Each tablet contains 1 mg of colchicine, a potent anti-inflammatory agent that alleviates pain and inflammation associated with gout flare-ups.
Indications:
This medication is indicated for the treatment of acute gout crises and for preventing new crises in individuals suffering from chronic gouty arthritis.
Dosage and Administration:
The recommended dosage for acute gout attacks is 1 mg (one tablet) at the first sign of an attack. If pain persists, a second dose of 1 mg may be administered one to two hours later, with a maximum limit of 2 mg within a 24-hour period.
Clinical Benefits:
Colchicina/Acarpia effectively reduces the pain and inflammation associated with acute gout attacks, providing relief to patients and supporting joint health.
Active Ingredients:
Each tablet contains 1 mg of colchicine as the active ingredient.
Warnings and Contraindications:
Use of this medication should be under medical supervision due to the narrow therapeutic margin of colchicine. It is contraindicated in patients with known allergies to colchicine and in those with severe gastrointestinal, hepatic, renal, or cardiac diseases.
Side Effects:
Possible side effects may include diarrhea, nausea, vomiting, abdominal cramps, and pain. It is essential to adhere to medical guidance regarding dosage and treatment duration to avoid health risks associated with self-medication.
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
